Citadel Advisors’s CalciMedica CALC Stock Holding History

Citadel Advisors’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36	Closed	-$250	–	14760
2022 Q4	$250	Buy	+36	New	+$404	﹤0.01%	14708
2022 Q3	–	Sell	-850	Closed	-$13K	–	12668
2022 Q2	$13K	Sell	850 -86	-9%	-$1.17K	﹤0.01%	12521
2022 Q1	$16K	Sell	936 -1,050	-53%	-$20K	﹤0.01%	13295
2021 Q4	$51K	Sell	1,986 -2,214	-53%	-$86K	﹤0.01%	13238
2021 Q3	$195K	Sell	4,200 -4,186	-50%	-$235K	﹤0.01%	12021
2021 Q2	$637K	Buy	+8,386	New	+$550K	﹤0.01%	9472

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors's CALC Position: Q2 2022 in Review

Citadel Advisors sold out of CalciMedica (CALC) in Q2 2022, closing a stake of 3,686 shares — an estimated $50.3K sold.

Citadel Advisors first reported a position in CALC in Q3 2020 and held it in 4 quarters. The position peaked at $4.96M in Q3 2020. 25 funds tracked by Wall St. Rank hold CALC as of Q2 2022.

Citadel Advisors reported no remaining CalciMedica position as of Q2 2022 after selling out during the quarter.
Citadel Advisors sold 3,686 CalciMedica shares in Q2 2022, an estimated $50.3K.
Citadel Advisors first reported a position in CalciMedica in Q3 2020 and held it in 4 quarters.
Citadel Advisors's CalciMedica position peaked at $4.96M in Q3 2020.
25 funds tracked by Wall St. Rank held CalciMedica as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.